EU’s new clinical trial system aims to streamline approvals and improve transparency
BMJ 2022; 376 doi: https://doi.org/10.1136/bmj.o228 (Published 26 January 2022) Cite this as: BMJ 2022;376:o228
- Elisabeth Mahase
- The BMJ
The EU Clinical Trials Regulation is set to come into effect on 31 January 2022 and will include a new streamlined system for trial sponsors and regulators, the European Medicines Agency (EMA) has announced.1
The Clinical Trials Information System (CTIS), which comes after a decade of work, will mean sponsors no longer have to submit clinical trial applications separately to each of the 30 national authorities and ethics committees. It also provides a single place where results can be published and will include a searchable database for healthcare professionals and the public.
The regulation will apply to EU and the …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.